Chemical and Biological Assessment of a Traditional Chinese Herbal Decoction Prepared from Radix Astragali and Radix Angelicae Sinensis: Orthogonal Array Design to Optimize the Extraction of Chemical Constituents

Abstract

Danggui Buxue Tang (DBT) is a simple decoction, having about 800 years of usage in China to treat menopausal irregularity in women, which contains two herbs: Radix Astragali (Huangqi) and Radix Angelicae Sinensis (Danggui). Traditionally, boiling water has been used for preparing DBT; however, the optimized conditions of extraction have not yet been determined. Here, the amounts of Radix Astragali-derived astragaloside IV, calycosin, formononetin, and Radix Angelicae Sinensis-derived ferulic acid and ligustilide were determined in DBT, which were extracted according to an orthogonal array experimental design having three variable parameters: extraction time, extraction volume and number of repeats of the extraction. Our results suggest that extraction time and number of repeats of the extraction are two crucial factors, while extraction volume is a subordinate factor. The optimized conditions for extraction were therefore established. Besides the chemical composition, the estrogenic and anti-platelet aggregation activities of DBT were determined in different groups of the extraction, and the results of bioassays were in line with the amounts of the analyzed chemical ingredients. The results provide a model system for establishing the quality assurance of the herbal preparation.

Angelica sinensis - Umbelliferae - Astragalus membranaceus var. - mongolicus - Leguminosae - Chinese medicine - quality assurance - extraction

References

• 1 Ning L, Chen C X, Jin R M, Wu Y P, Zhang H G, Sun C L, Song C Q, Hu Z B. Effect of components of Dang-Gui-Bu-Xue decoction on hematopenia.  Chin J Chin Mat Med. 2002;  27 50-3
• 2 Wu D Z, Song C Q, Hen Z F, Kong J L, Fan Y, Hu Z B. Effects of Angelicae Sinensis decoction for supplementing blood on the cardiac function in myocardial ischemia reperfusion injury of rats.  Pharm Clin Chin Mat Med. 1999;  15 3-6
• 3 Zheng X Y. Pharmacopoeia of the People’s Republic of China. Beijing; Chemical Industry Press, China 2000: pp 158, 161
• 4 Sinclair S. Chinese herbs: a clinical review of Astragalus, Ligusticum, and Schizandra .  Altern Med Rev. 1998;  3 338-44
• 5 Wagner H, Bauer R, Xiao P G, Chen J M, Michler G. Chinese Drug Monographs and Analysis: Radix Astragali (Huangqi). Wald Verlag Germany; 1997: pp 1-17
• 6 Ma X Q, Shi Q, Duan J A, Dong T TX, Tsim K WK. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations.  J Agric Food Chem. 2002;  50 4861-6
• 7 Wagner H, Bauer R, Xiao P G, Chen J M, Michler G. Chinese Monographs and Analysis: Angelica sinensis. Wald Verlag Germany; 2001 Vol. 3
• 8 Zhao K J, Dong T TX, Tu P F, Song Z H, Lo C K, Tsim K WK. Molecular genetic and chemical assessment of Radix Angelicae (Danggui) in China.  J Agric Food Chem. 2003;  51 2576-83
• 9 Liu J, Burdette J E, Xu H, Gu C, Breemen R B, Bhat K P, Booth N, Constantinou A I, Pezzuto J M, Fong H H, Farnsworth N R, Bolton J L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms.  J Agric Food Chem. 2001;  49 2472-9
• 10 Mineo S, Takayasu M, Syoichi S; Masao Y; Naokata M. Evaluation of Angelicae Radix (Touki) by the inhibitory effect on platelet aggregation.  Chem Pharm Bull. 1991;  39 2046-8
• 11 Wilasrusmee C, Kittur S, Siddiqui J, Bruch D, Wilasrusmee S, Kittur D S. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes.  J Altern Complement Med. 2002;  8 467-75
• 12 Ma X Q, Duan J A, Zhu D Y, Dong T X, Tsim K WK. Chemical comparison of Astragali Radix (Huangqi) from different regions of China.  Nat Med. 2000;  54 213-8
• 13 Li S P, Zhao K J, Ji Z N, Song Z H, Dong T TX, Lo C K, Cheung J KH, Zhu S Q, Tsim K WK. A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury.  Life Sci. 2003;  73 2503-13
• 14 Ilbbotson K J, Harrod J, Gowen M, D’Souza S, Smith D D, Winkler M E, Derynck R, Mundy G R. Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro .  Proc Natl Acad Sci USA. 1986;  83 2228-32
• 15 Ashida S I, Abiko Y. Inhibition of platelet aggregation by a new agent, Ticlopidine.  Thromb Haemost. 1979;  40 542-50
• 16 Bauer R, Tittel G. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies.  Phytomedicine. 1996;  2 193-8